Stay updated on SAGE-547 for Status Epilepticus Clinical Trial
Sign up to get notified when there's something new on the SAGE-547 for Status Epilepticus Clinical Trial page.

Latest updates to the SAGE-547 for Status Epilepticus Clinical Trial page
- Check2 days agoChange DetectedThe government funding notice banner at the top of the page has been removed.SummaryDifference0.6%

- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedThe new screenshot indicates styling/layout changes to the page without altering core study information (eligibility, interventions, or outcomes). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check45 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference7%

- Check52 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0 to reflect a newer version.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page now references Supernus Pharmaceuticals, Inc. with newer dates (2025) and a revised update label, replacing Sage Therapeutics and older 2017 dates. This indicates a branding/ownership update and refreshed timestamping.SummaryDifference3%

- Check67 days agoChange DetectedThe page now shows Revision: v3.0.2 (replacing v3.0.1), and the Back to Top link was removed.SummaryDifference0.4%

Stay in the know with updates to SAGE-547 for Status Epilepticus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-547 for Status Epilepticus Clinical Trial page.